Evaluation variables , including changes in serum lipid profiles , degree of stenosis , and perfusion-related parameters derived from computed tomography perfusion ( CTP ) imaging from baseline to weeks 26 and 52 , as well as the occurrence of cerebrovascular events during the study period , were used to compare the benefits of these three statin therapies .